Biotech VC Funds

Nissay Capital, a venture capital firm based in Tokyo and wholly owned by Nippon Life Insurance Company, has a rich history of investments across various stages and sectors. With over 1,200 unlisted companies and 226 IPOs since its inception in 1991, the firm is a significant player in Japan's venture capital landscape. Notable investments include Heartseed, a biotech company, SkyDisc, and LaFabric. They focus on early to growth-stage businesses, with investments ranging from $4M to $740M. Nissay Capital's strategy emphasizes leveraging the vast network of Nippon Life Insurance to support portfolio companies, providing extensive guidance on management strategies and capital policies. They prefer investing in innovative startups that align with their long-term vision of contributing to society, particularly in technology and healthcare sectors. The firm typically co-invests with other major players like Mitsubishi UFJ Capital and CyberAgent Capital, fostering a collaborative investment environment. Key team members include Eiji Arima, the President and CEO, who plays a pivotal role in steering the firm's strategic direction. Nissay Capital prefers entrepreneurs to approach them through well-researched pitches that clearly articulate the market opportunity and technological innovation. Active and involved, they are seen as a hands-on investor committed to the growth and success of their investees

NLC Health Ventures is an Amsterdam-based healthtech venture builder and investment fund founded in 2014 by Bert-Arjan Millenaar, who continues to lead the firm as Founder and CEO. NLC describes itself as the world's largest healthtech venture builder and, since 2023, has been recognized as the most active early-stage healthcare investor in its category. The firm operates across Europe and the United States, co-founding companies from scientific invention through to clinical deployment in biotech, medtech, digital health, and what NLC terms green health. NLC's model is entrepreneurial at scale: each year the firm assesses more than 1,500 scientific inventions submitted by universities, academic hospitals, and corporates across 40-plus countries, then selects 20 to 25 to spin out as new ventures. In 2024 alone NLC launched 20 new companies and secured a record EUR 43.6 million in funding across the portfolio. Across more than a decade the firm has co-founded over 110 ventures — 76 active as of 2024 — impacting more than 2 million patients. The flagship vehicle today is the NLC Health Impact Fund, an Article 9 SFDR-classified fund targeting EUR 100 million with follow-on capacity of up to EUR 9 million per company through Series A and B. Notable portfolio ventures include Nicolab, an AI-driven stroke treatment platform, and Concord Neonatal, a shock-free birth technology originating from Leiden University Medical Centre. NLC is a certified B Corp aligned to UN Sustainable Development Goals 3, 9, and 17. With more than 80 staff — including 40-plus healthcare specialists — the firm provides portfolio companies with regulatory, product development, and clinical trial support. Strategic partnerships include Minnesota MedTech 3.0, announced in February 2025, which connects European startups to the Minnesota medtech corridor.

No Label Ventures (NLV) is a London-based European pre-seed and seed-stage venture capital fund founded in 2022 and publicly launched in March 2023. The fund is led by solo General Partner Ramzi Rafih, whose family fled Lebanon during the civil war. Rafih began his career at J.P. Morgan and spent more than a decade as a late-stage investor at KKR and Silver Lake before transitioning to VC; approximately one-third of NLV's fund is anchored by his former KKR colleagues. NLV focuses exclusively on Europe and is positioned as the first institutional backer specifically for immigrant entrepreneurs, providing first cheques from day one before a lead VC commits. The fund writes tickets of $150,000 to $250,000, with the ability to upscale via LP co-investment. It is sector agnostic across SaaS, developer tools, SMB software, AI, biotech, agtech, climate tech, marketplaces, fintech, and therapeutics. Across nine disclosed investments, portfolio companies include Spore.Bio, which produces FMCG quality-control devices; Callyope, a speech-based remote patient monitoring company that raised a EUR 2.2 million round; Pangea Bio; Zango; Nozomio Labs; and POSTX. Several NLV-backed companies have gone on to raise from Sequoia Capital and other leading European and US firms. NLV's thesis rests on a documented investment inefficiency: immigrant founders in Europe typically raise at 14 percent lower valuations with 24 percent less funding, yet outperform better-capitalised peers by up to 70 percent. By providing unconditional first capital, visa and immigration workflow support, customer introductions, and downstream fundraising guidance, NLV offers a package of support that extends well beyond the cheque itself.

Noaber is a purpose-driven venture fund based in the Netherlands, with a mission to create meaningful and sustainable healthcare solutions. The firm invests in early-stage ventures that drive impactful innovations in healthcare, focusing on improving health outcomes while reducing costs and increasing both patient and provider satisfaction. Noaber’s investment strategy revolves around the “Quadruple Aim” of healthcare, which seeks to improve the overall health of populations, enhance the patient experience, reduce healthcare costs, and improve the work life of healthcare providers. The fund’s core investment areas include health activation, early screening and diagnostics, chronic disease management, and health system innovation. Examples of Noaber’s portfolio include Alba Health, which uses microbiome science and AI to prevent chronic diseases, and Momo Medical, which supports caregivers in nursing homes through advanced patient monitoring technology. Another noteworthy investment is Habitual, a digital intervention program that helps manage type 2 diabetes by providing scalable, cost-effective patient support. Noaber is heavily involved in the (pre-)seed stage and frequently serves as the first professional investor in companies. Although its primary focus is on ventures in the Benelux region, Germany, Austria, Switzerland, and Scandinavia, Noaber is expanding its reach through strategic partnerships, including plans to enter the U.S. market. In addition to direct investments, Noaber also participates in investment funds that share its vision for driving healthcare innovation. Noaber’s approach is hands-on, fostering close collaborations with entrepreneurs to inspire broader investment in socially impactful healthcare innovations.

Noetic Fund is a Toronto-based venture capital firm launched in 2020, specializing in early-stage investments within the healthcare, psychedelic medicine, and biotech sectors. The fund focuses on emerging therapies and technologies aimed at improving mental health, addressing central nervous system disorders, and offering innovative solutions to global healthcare challenges. Noetic is particularly involved in the burgeoning field of psychedelic-based therapeutics, where they support companies working on treatments for conditions such as depression, PTSD, and substance use disorders. With its first fund, Noetic made around 20 investments, including notable companies like COMPASS Pathways, MindMed, and Cybin, all leaders in the psychedelic medicine space. They’ve continued to expand with the launch of Noetic Fund II, aiming to raise $200 million to further invest in groundbreaking therapies. Their strategy includes a long-term focus on companies developing new drug discoveries, digital health solutions, and medical devices that address unmet needs in mental and physical health. Noetic’s leadership includes seasoned venture capitalists and experts in life sciences, positioning the firm to capitalize on the growing acceptance and scientific validation of psychedelic treatments. They collaborate closely with portfolio companies, leveraging their expertise to foster sustainable growth and innovation.

Nomad Ventures is an early-stage VC firm based in Los Angeles, with a strong focus on high-growth, network-effect businesses. Their sector-agnostic approach includes fintech, consumer tech, vertical SaaS, and marketplaces, backing startups that drive new ways for people to earn money online. With notable investments in companies like Cameo and Wheels, Nomad Ventures has a track record of identifying disruptive, scalable business models. The fund primarily targets pre-seed and seed-stage investments, aiming to partner with founders who exhibit grit and a bold vision for the future. They seek startups with operational intensity and scalable distribution advantages. While geographically anchored in the U.S., particularly cities like Los Angeles, New York, Austin, and Miami, they are open to the growing decentralization of startup ecosystems across the country. Led by Chris Taylor, James Mumma, and Marco McCottry—all experienced operators who played key roles at Uber, Bird, and Opendoor—the team brings hands-on expertise and operational guidance to their portfolio companies. They actively co-invest with top-tier VCs like Andreessen Horowitz, often helping lead rounds with average check sizes ranging from $250K to $1M. Nomad is known for being approachable and looking for founders who build defensible businesses with strong marketplace dynamics. Nomad Ventures has raised over $100M and frequently scouts startups through industry relationships and tech scene connections, with a preference for companies demonstrating early, clear traction.

NOMO Ventures is a venture capital firm specializing in early-stage investments in transformative technology companies. With over $100 million in assets under management, NOMO Ventures has a diverse portfolio that includes prominent companies such as Expensify, Nest, MeUndies, Simulate, Better Mortgage, Ponto, Batch, and Railz​ (HealthTech Alpha)​​ (Unicorn Nest)​. Their investment strategy focuses on early-stage ventures, often co-investing with other notable funds like Global Founders Capital and Pioneer Fund. NOMO Ventures tends to back companies that offer innovative solutions and have the potential for significant market impact. They have made investments in a variety of sectors, including health tech, fintech, and consumer products. NOMO Ventures is based in San Francisco and is actively seeking new investments, typically participating in funding rounds ranging from $2 million to $20 million. They have a track record of investing in startups that achieve high growth and profitability. For instance, recent investments include Great Question, a customer research platform, and Pry Financials, which simplifies startup finances​. Key team members include experienced venture investors who provide hands-on support and strategic guidance to their portfolio companies. NOMO Ventures looks for startups with strong, innovative business models and clear market potential. Startups interested in securing investment from NOMO Ventures should prepare a direct and concise pitch that highlights scalability and strategic fit with NOMO's investment focus​.

NOON Ventures is a Copenhagen-based early-stage venture fund, launched in 2020 by Caspar Høgh and Theis Malmborg. The fund focuses on investing in transformative technologies that tackle environmental and climate challenges. With a hands-on approach, NOON Ventures works closely with its portfolio companies, acting as co-developers to support long-term growth. Their sectors of interest include biotech, clean energy, manufacturing, and sustainability, specifically targeting companies in Northern Europe. The fund typically leads or co-leads investments, with check sizes ranging from €2-5 million. Its notable investments include Spectro Inlets, Enduro Genetics, and Lotus Microsystems, all working on innovative solutions in sustainability and tech. NOON Ventures emphasizes its commitment to limiting the number of investments, ensuring they can deeply engage with each startup across strategy, talent acquisition, and customer growth. NOON Ventures has made sustainability central to its mission, and its investments align with this philosophy, aiming to contribute to the UN's Sustainable Development Goals. Entrepreneurs with proven technology and a passion for environmental impact will find an ideal partner in NOON Ventures, especially if they seek more than just financial backing.

Nordic Alpha Partners (NAP) is a Copenhagen and Munich-based growth equity fund specializing in scaling industrial GreenTech companies. Established in 2017, NAP manages over €275 million across its funds, focusing on helping visionary founders expand their operations from local players to global leaders. The firm’s unique operational approach emphasizes active engagement, with partners working closely with portfolio companies for up to a year before formal investment. This de-risks ventures and supports rapid, capital-efficient growth. NAP's investment strategy is rooted in sustainability, specifically targeting “dark green” companies that contribute to the global green transition. NAP's impact is demonstrated by the abatement of over 1.1 million tonnes of CO2 and the creation of more than 700 jobs across its portfolio. Notable investments include AquaGreen, which revolutionizes biomass pyrolysis for energy and nutrient recovery, and Green Hydrogen Systems, a leader in the green hydrogen revolution. With strong backing from investors like Allianz Global Investors, Novo Holdings, and KfW Capital, NAP has emerged as a leader in the GreenTech space. Their approach is supported by an extensive value-creation toolkit, which guides companies through the complexities of scaling capital-intensive technologies. NAP also fosters future GreenTech leaders by collaborating with academic institutions, including the Technical University of Denmark. Committed to economic sustainability, NAP helps fuel the growth of next-generation companies that drive the global green transformation while ensuring long-term financial success for their investors.

NFT Ventures, established in 2014 and based in Stockholm, is a prominent venture capital firm specializing in fintech investments. The firm has carved out a niche within the Nordic fintech ecosystem, backing startups that are transforming the financial industry through innovative technologies. NFT Ventures focuses on a broad range of fintech verticals, including regtech, insurtech, and more, investing in companies that have significant scalability and growth potential. NFT Ventures is an active investor, often taking board seats to provide strategic guidance and operational support to its portfolio companies. The firm has built a diverse portfolio of around 40 companies, including notable names like Gimi, a financial education app for children, and Lunar, a modern digital bank. Their approach extends beyond mere financial investment; they leverage their extensive network and deep industry expertise to help their portfolio companies succeed. With a strong presence in Northern Europe, NFT Ventures is well-positioned to continue driving fintech innovation across the region.

Nordic Makers, established in 2016, is an early-stage investment firm founded by a group of experienced angel investors from the Nordic region. The firm focuses on seed and early-stage investments, primarily in technology-driven startups across the Nordics and Europe. Their investment philosophy centers on providing founder-friendly terms and leveraging their extensive network to support entrepreneurial growth. Notable investments by Nordic Makers include Labster, a leading provider of virtual science labs; Seaborg Technologies, which is developing sustainable nuclear reactor technology; and NextMind, which creates brain-sensing wearable devices for real-time device control. Other significant investments include Willa Pay, Helix Nano, LetsBuild, Singa, and Climateview​. The firm’s founding partners, such as Klaus Nyengaard, Esben Gadsbøll, and Alexander Aghassipour, bring a wealth of experience from successful ventures like Just Eat, WhiteAway, and Zendesk. They focus on fostering cross-border investments and integrating the Nordic and Baltic startup ecosystems.

NordicNinja VC is a leading venture capital fund with a €200 million second fund targeting climate tech and deep tech startups across Northern Europe, the UK, and the Benelux. Founded in 2019, the firm is a joint venture backed by Japan Bank for International Cooperation (JBIC), Honda, Omron, and European investors like BaltCap and Swedbank. NordicNinja invests between €2.5 to €10 million in Series A and B rounds, supporting founders addressing global challenges in sustainability, digitalization, and innovative tech solutions. The fund’s portfolio includes high-profile companies like Bolt, Veriff, Einride, and Voi, emphasizing sectors such as electric and autonomous mobility, AI, and immersive digital tools. While around half of NordicNinja’s investments are concentrated in mobility and transportation due to their potential for significant carbon reduction, the firm has also backed companies in sectors like healthcare and digital identity verification, leveraging AI and mixed reality to solve pressing societal problems. Led by managing partners Shinichi Nikkuni, Marek Kiisa, Rainer Sternfeld, and Tomosaku Sohara, the team combines deep expertise in engineering, green energy, and international business. This allows NordicNinja to bridge Japanese and European ecosystems, offering founders access to Japanese corporate networks, enhancing market reach, and supporting scalable, impactful innovation. The fund prioritizes founders with ambitious visions and a readiness to lead in creating a sustainable, tech-driven future, making NordicNinja an ideal partner for startups ready to tackle the world's most critical challenges.

Norrsken VC is a prominent European venture capital firm focused on impact investing, founded in 2017 in Sweden. The firm supports startups that address significant global challenges while aiming for substantial financial returns. Norrsken VC specializes in sectors such as climate tech, energy, biotech, AI, and health tech, ensuring each investment aligns with the UN Sustainable Development Goals (SDGs)​​. Norrsken VC's portfolio includes high-impact companies like Northvolt, a battery manufacturer; Einride, which develops electric autonomous transport; and 1KOMMA5°, focused on sustainable energy solutions. These companies exemplify Norrsken's commitment to backing startups that positively impact both people and the planet​. The firm recently closed its second fund at €320 million, surpassing its original target of €250 million, making it the largest early-stage generalist impact fund in Europe. This fund is supported by major institutional investors, including Folksam, AP1, and the European Investment Fund (EIF), and aims to empower "force of nature" founders to create impact unicorns​. Norrsken VC's team comprises experienced venture capitalists and industry experts, including General Partners Niklas Adalberth, Tove Larsson, Agate Freimane, and David Frykman. The team is dedicated to finding visionary founders across Europe who share their passion for creating a better future through innovative solutions​.

North Bridge Venture Partners, founded in 1994 and based in Wellesley, Massachusetts, is a venture capital firm that provides seed-to-growth financing. The firm focuses on several key sectors, including communications and infrastructure, software, materials, healthcare, and digital media. North Bridge Venture Partners supports companies from their initial stages through to becoming market leaders, leveraging a combination of operational experience and strategic guidance​. The firm has made over 479 investments and has achieved 183 exits. Notable portfolio companies include Couchbase, Markforged, and Lyra Therapeutics. North Bridge has a significant presence in the U.S. market, focusing primarily on early-stage and growth-stage companies operating in healthcare and information technology sectors​. North Bridge is led by a team of experienced professionals, including founder and managing partner Edward Anderson and general partners Richard D'Amore and Jeffrey McCarthy. The firm's strategy emphasizes investing in exceptional entrepreneurs whose ideas have the potential to disrupt their respective industries.

North Shore InnoVentures (NSIV) is a non-profit incubator focused on accelerating the growth of early-stage life sciences and cleantech startups. Based in Beverly, Massachusetts, NSIV provides crucial support through shared lab space, resources, and business mentoring. With two main incubator facilities—the Biotech InnoVenture Center and the Cleantech InnoVenture Center—NSIV has supported over 70 companies since its founding in 2009. Collectively, these startups have raised over $1 billion in funding and created more than 500 jobs​. NSIV specializes in helping companies in the life sciences, healthcare, medical devices, and clean energy sectors. Its investment strategy focuses on early and seed-stag. Led by CEO Chris Ilsley, NSIV emphasizes creating a collaborative environment that nurtures innovation. Companies at NSIV benefit from mentoring programs, expert advisory panels, and connections with potential investors, making it an ideal launching pad for early-stage ventures​.

The North West Fund is a £155 million investment fund aimed at supporting small and medium-sized enterprises (SMEs) in the North West of England. Managed by North West Business Finance Limited, an independent private sector company, the fund was established to address gaps in lending, venture capital, and private equity markets. The fund has been fully invested, supporting over 443 businesses and creating more than 6,300 jobs in the region. The fund comprises several sub-funds, each managed by different fund managers, providing a range of financial support from equity investments to loans. These sub-funds include The North West Fund for Venture Capital, Mezzanine, Loans Plus, Micro Loans, Energy and Environmental, Biomedical, and Digital and Creative. These funds have been instrumental in facilitating the growth and expansion of innovative businesses across various sectors. The North West Fund has a strong team of experienced professionals, including Cliff Maylor (Chief Executive Officer), Neil Morrey (Chief Operating Officer), and Mike Kenyon (Chief Financial Officer). The fund's governance is supported by an independent Board and an Investment Advisory Panel with expertise in private equity, venture capital, and the targeted sectors.

North West Quadrant (NWQ) Ventures, based in Menlo Park, California, is a venture capital firm that specializes in early-stage investments in disruptive technologies. Founded in 2010, NWQ Ventures primarily focuses on companies that are pushing the boundaries of innovation, particularly in sectors like digital media, fintech, and real estate services. NWQ Ventures supports startups that aim to achieve something unprecedented, providing them not just with capital, but also with strategic guidance on patents, manufacturing, market entry, and venture debt financing. The firm has a global outlook and takes a hands-on approach with its portfolio companies, helping them scale through mid-stage growth financing and by leveraging a strong network of co-investors and partners. NWQ's portfolio includes diverse investments like MoonPay and Typewise, showcasing its commitment to high-growth industries. The firm's strategy centers around helping these early-stage companies reach significant milestones by offering both financial and strategic resources. NWQ Ventures operates with a forward-thinking investment thesis, targeting companies that have the potential to reshape their respective industries and create lasting impact. The firm plays a crucial role in bringing new technological advancements to market, ensuring that the startups it backs are well-positioned for success​.

Northern Gritstone is a venture capital firm established in 2020, focused on commercializing cutting-edge science and technology emerging from the North of England. With headquarters in Manchester and strong ties to the Universities of Manchester, Leeds, and Sheffield, Northern Gritstone primarily invests in early-stage companies that originate from these institutions or are based in the region. The firm manages a substantial fund, recently closing at £312 million, to support startups in sectors like deep technology, life sciences, healthcare, and advanced materials. Northern Gritstone's investment strategy is driven by a philosophy of "profit with purpose," aiming to generate financial returns while also contributing to the economic development of the North of England. Northern Gritstone has already made significant investments in companies such as Optalysys, a photonic chip firm, and AssetCool, which develops advanced coatings for industrial applications. The firm is committed to fostering a tech ecosystem in the region, aspiring to create a "Silicon Valley of the North" by backing visionary companies with strong intellectual property and high growth potential.

Northern Light Venture Capital (NLVC) is a US-China cross-border venture capital firm founded in 2005 by Managing Directors Feng Deng, Yan Ke, and Jeffrey Lee. The firm is dual-headquartered in Menlo Park, California with major operating offices in Shanghai and Beijing. Founders Feng Deng and Yan Ke previously co-founded NetScreen Technologies, an enterprise IT-security company that IPO'd on Nasdaq in 2001 and was acquired by Juniper Networks in 2004 for $4.2 billion. NLVC's first fund was anchored by New Enterprise Associates, Greylock Partners, and WebEx co-founder Min Zhu. Today NLVC manages over $4.5 billion across multiple US-dollar and RMB-denominated funds, with its latest flagship being Northern Light Venture Fund V. NLVC leads rounds and invests across seed, Series A, and Series B stages, with a thesis split roughly 70 percent Series A, 20 percent Series B, and 10 percent seed. The investment focus spans TMT, consumer, green tech, and life sciences, with a 'China concept' mandate: companies that leverage China's industrial, economic, or human resources to build lasting global businesses. Across more than 300 portfolio investments, NLVC has produced 13 unicorns, 15 IPOs, and 23 acquisitions. Marquee wins include Meituan, which IPO'd in Hong Kong; Carta, the US cap-table SaaS platform; VIPKid; Aerohive Networks; and Linekong. In 2024 Taimei Technology IPO'd on HKEX at a $937 million market cap, and GenFleet Therapeutics followed in 2025 at $936 million. NLVC operates with deep bench strength across the US-China corridor, enabling portfolio companies to access manufacturing, talent, and distribution resources on both sides of the Pacific. The firm's track record across more than two decades of cross-border investing has made it one of the most consequential China-linked VC firms globally.

NPV Ventures is a venture capital firm that focuses on investing in early-stage technology companies, particularly in fintech, consumer tech, and enterprise software. The firm seeks to partner with founders who are building transformative solutions that have the potential to disrupt their industries. NPV Ventures is known for its hands-on approach, working closely with its portfolio companies to provide not just capital but also strategic guidance, operational expertise, and access to a vast network of industry leaders and investors. Founded by a group of seasoned entrepreneurs and investors, NPV Ventures aims to be the first institutional capital into a startup, often investing at the seed and pre-seed stages. The firm takes pride in backing high-growth potential companies and helping them scale by leveraging their deep industry insights and connections. Their portfolio includes innovative startups that are making significant strides in their respective markets. NPV Ventures typically writes initial checks in the range of $250,000 to $1 million and continues to support its companies through follow-on investments. The firm is particularly interested in startups that are solving complex problems with scalable business models, and they prefer to work with founders who demonstrate strong vision, leadership, and execution capabilities. With a focus on both U.S. and international markets, NPV Ventures continues to play a significant role in shaping the future of the tech landscape by backing visionary entrepreneurs and game-changing companies.

Northstar Ventures is a UK-based venture capital firm focused on early-stage investments that create a positive social or environmental impact. With a portfolio that spans tech innovation and social enterprises, the firm emphasizes sectors like climate tech, biotech, and healthy aging. Their notable investments include Newcells Biotech, which develops in vitro organ models for drug testing, and NunaBio, a leader in DNA synthesis technology crucial for personalized medicine and data storage solutions​. Geographically, Northstar Ventures primarily focuses on startups in the North East of England but also supports businesses across the UK. They invest through funds such as the North East Innovation Fund and the Northstar EIS Growth Fund, with typical early-stage investments ranging from £300,000 to £1 million​. Their hands-on approach includes extensive support for founders, particularly in sectors that align with sustainability goals, like Low Carbon Materials, which develops environmentally friendly construction materials. Northstar also backs social impact ventures, such as Coping with Cancer North East, reflecting their commitment to community well-being alongside technological innovation.

Norwest Venture Partners (NVP), headquartered in Menlo Park, California, is a prominent venture capital and growth equity investment firm managing over $15.5 billion in capital. Founded in 1961, Norwest has invested in more than 700 companies across various sectors, including enterprise, consumer, and healthcare. Some of their notable investments include companies like Spotify, Adaptive Insights, Udemy, Talkspace, Opendoor, Kendra Scott, and Health Catalyst. These investments highlight Norwest's diversified approach, backing high-impact companies at various stages of growth from early to late-stage. Norwest recently announced the closing of its seventeenth fund, NVP 17, raising $3 billion to continue supporting visionary entrepreneurs. The firm operates globally with offices in Menlo Park, San Francisco, Mumbai, and Tel Aviv, focusing on North America, India, and Israel​. With a strong commitment to their portfolio companies, Norwest offers extensive support through their experienced investment and portfolio services teams, helping businesses navigate growth and scale effectively. This hands-on approach has contributed to their track record of successful exits and sustained growth in their portfolio companies​.

Notation Capital, established in 2015 by Nicholas Chirls and Alex Lines, is a pioneering pre-seed venture capital firm based in Brooklyn, New York. Specializing in early-stage investments, Notation Capital supports technical teams at the inception of their business journeys, often at the idea stage. Notation's notable investments include Spruce, Livepeer, Bison Trails, and Parsec, showcasing their focus on hard tech, infrastructure, and product-centric startups. The fund is heavily focused on the New York City area but does not limit itself geographically if the opportunity aligns well with their investment philosophy. They typically lead the first round of financing with investment sizes ranging from $250K to $750K. Their strategy emphasizes deep involvement from day one, providing not just capital but also substantial operational support, leveraging their extensive network of advisors, founders, and LPs to accelerate growth and product development. Key team members include Nicholas Chirls, who brings expertise in product development and growth strategies from his previous role at betaworks, and Alex Lines, a seasoned software engineer with a decade of experience in building scalable products. Startups looking to engage with Notation Capital should demonstrate a strong technical foundation and a compelling vision for disruptive innovation. They prefer founders who are deeply product-focused and exhibit a strong determination to execute their vision.

New Venture Fund (Norwest Venture Partners) is a leading venture capital and growth equity investment firm with a diversified investment strategy. It focuses on early- to late-stage investments across various sectors, including consumer, enterprise, and healthcare. Norwest has a robust global presence with offices in North America, India, and Israel, enabling it to identify and support innovative companies worldwide. Notable investments by Norwest include companies like Dave, Gong, Swiggy, Udemy, Vuori, and Ritual. These investments demonstrate the firm's commitment to backing visionary leaders and transformative businesses. Norwest’s investment strategy includes providing not only capital but also strategic guidance and operational support to help portfolio companies scale and achieve significant growth. The firm has recently launched its $3 billion fund, NVP XVI, to continue empowering high-impact businesses. In recent years, Norwest has expanded its focus within the healthcare sector to include biotechnology, building on its successes in medical devices, diagnostics, and healthcare services. Norwest's notable exits include companies such as Opendoor, Talkspace, Udemy, Aporeto, CyberX, and Shape Security, among others. The firm is also committed to environmental, social, and governance (ESG) principles, investing in companies that prioritize sustainability and social impact​.

Novo Holdings is a premier life sciences investment firm based in Copenhagen, Denmark, with additional offices in Boston, San Francisco, London, and Singapore. The firm is wholly owned by the Novo Nordisk Foundation and manages an extensive portfolio aimed at generating long-term returns while advancing health and sustainability. Novo Holdings focuses on investments across biotechnology, medical technology, and digital health sectors, supporting companies at various stages, from early development to commercial phases. In 2023, the firm deployed DKK 3.6 billion, including significant investments in 4D Molecular, Alentis Therapeutics, and Lexeo Therapeutics. The firm's strategy emphasizes innovation in patient care and strong financial returns. Notably, Novo Holdings operates with an evergreen fund structure, allowing a long-term perspective on its investments. The firm actively engages with portfolio companies, often taking board positions to leverage its vast network and expertise. The investment team, led by Managing Partner Scott Beardsley, comprises professionals across major life science hubs. Key team members include Amit Kakar, Head of Novo Holdings Asia, and Anna Fan, Senior Partner in the Life Sciences Operating Committee. For startups seeking investment, Novo Holdings values groundbreaking science and robust clinical data, favoring companies with late preclinical or clinical stage compounds in biotech, and commercial stage entities in medtech and digital health

Novus Ventures was a Cupertino, California-based early-stage venture capital firm founded in 1994 by Dan Tompkins and Greg Lahann, specializing in information technology and select life sciences investments. Headquartered at Stevens Creek Boulevard in Cupertino, the firm operated with approximately six professionals including four partners; leadership included Managing General Partner Dan Tompkins and General Partner and Founding Member Shirley Cerrudo. Novus deployed Series A cheques in the $500,000 to $1 million range into US-based startups where the partners could make both financial and strategic contributions as active investor-operators. Sector concentration spanned enterprise software and applications, infrastructure, semiconductors, networking, systems, and select life sciences. Across more than 20 years of activity the firm made 71 investments and produced four acquisition exits. Notable portfolio companies include MBlox, a mobile messaging company acquired by CLX Communications in 2016; Voltaix, a specialty electronic materials company acquired by Air Liquide in 2013; Tidal Software, a workload automation platform acquired by Cisco; Pathwork Diagnostics, a cancer diagnostics company; and LoveTheSign, an Italian designer-furniture e-commerce platform that represented the firm's last recorded investment in April 2015. Novus Ventures is now permanently closed and no longer makes new investments. The entity continues to exist primarily for legacy portfolio management. Its 20-year record spanning Silicon Valley's enterprise software and semiconductor buildout stands as a complete chapter of early-stage IT investing in the region.

NP-Hard Ventures is an early-stage venture capital fund based in Amsterdam, Netherlands, focused on investing in product-obsessed founders. The firm targets pre-seed and seed stage startups in Europe and the US, particularly those building infrastructure, tools, and decentralized platforms that simplify and enhance productivity. Founded in 2021 by Anke Huiskes, Micha Hernandez van Leuffen, and Paul Veugen, NP-Hard Ventures has raised €12 million in its inaugural fund, exceeding their initial target of €10 million. The fund plans to invest average checks of €250,000 into around 20 startups, reserving 25% of the fund for follow-on investments. Their portfolio includes innovative companies like Tldraw, an open-source drawing tool for software design, and Emidat, a platform aimed at reducing emissions in the construction industry. The firm is particularly interested in software startups with technical founders who are developing enterprise solutions​. NP-Hard Ventures is distinguished by its operational experience, with the founders having collectively invested in over 50 early-stage companies and 15 funds across Europe and the US. The team aims to bring a sense of urgency and competitive edge from their experiences in the San Francisco tech scene to the European startup ecosystem​.

Nucleus Capital, founded in 2020 and based in Berlin, Germany, is a venture capital firm dedicated to supporting early-stage, purpose-driven entrepreneurs tackling systemic challenges to planetary health. They focus on three main sectors: programmable biology, food technology, and green industrials. Notable investments by Nucleus Capital include Yuri, a space biotech company; Planet A Foods, which develops biotech-derived food ingredients; and Hier Foods, a digital platform for food distribution. Other key investments encompass innovative startups like Farmless, which transforms renewable energy into food, and Brineworks, which focuses on ocean-based CO2 removal through electrochemistry​. Nucleus Capital typically invests in pre-seed and seed stages with check sizes ranging from €150k to €1 million. They aim to partner with mission-driven teams possessing deep domain expertise and creative solutions to global environmental challenges​​. The firm is led by co-founders Maximilian Schwarz and Isabella Fandrych, who bring significant expertise and a strong commitment to fostering entrepreneurial innovation for planetary health​.

Nutreco is a global leader in animal nutrition and aquafeed, committed to sustainably feeding the growing global population. Headquartered in the Netherlands, Nutreco operates through two primary business lines: Skretting, which focuses on aquaculture, and Trouw Nutrition, which serves the livestock industry. The company’s overarching mission, known as "Feeding the Future," is to drive sustainability across the entire food production chain. Nutreco's strategy is centered around three main areas: supporting sustainable production through technology, advancing nutrition and animal health, and sourcing future protein ingredients. The company is heavily invested in developing sustainable alternatives to traditional feed ingredients, including the use of insect protein and other novel sources. This approach aims to reduce the environmental footprint of animal farming, which is crucial as feed ingredient production currently accounts for a significant portion of greenhouse gas emissions in the livestock industry. Innovation is a key pillar of Nutreco's operations, primarily driven by their NuFrontiers team, which focuses on breakthrough technologies that can transform the protein value chain. Nutreco has also been expanding its production capabilities in growth markets like Asia and Latin America, as well as optimizing its operations to increase agility and reduce costs. The company’s investments are aimed at not just expanding its market presence but also ensuring that its products and practices are aligned with global sustainability goals, making it a crucial player in the future of food production​.

NXTP Ventures, headquartered in Buenos Aires, is a leading venture capital firm in Latin America, focusing on early-stage tech startups. Their portfolio includes high-growth companies like Auth0, Nuvemshop, and Satellogic. With over 130 investments and numerous successful exits, NXTP is known for supporting innovative ventures in SaaS, logistics, and fintech sectors. They typically invest in Seed and Series A rounds, writing checks between $500k and $2 million. NXTP's strategy involves deep engagement with their portfolio companies, providing not just capital but also operational support, strategic guidance, and access to an extensive network of industry specialists and mentors. This approach has helped many of their investments achieve significant growth and market presence​ . The firm’s key team members, such as co-founder Ariel Arrieta, bring a wealth of experience in both investing and operating within the tech ecosystem. NXTP's investments are spread across Latin America, with a strong presence in Brazil, Argentina, Mexico, Chile, and Colombia.

Oak Investment Partners is a leading multi-stage venture capital firm that focuses on high-growth opportunities across several sectors, including information technology, financial services technology, healthcare, and clean energy. Founded in 1978, Oak has invested over $9 billion in more than 525 companies worldwide. The firm is known for its hands-on approach, offering comprehensive support and strategic assistance through its extensive network of industry experts. Oak's portfolio includes notable companies such as Castlight Health, Zayo Group, Kayak, Benefitfocus, and Protean Electric, among others. Their investment strategy spans early to late-stage investments, including growth equity and PIPE (private investment in public equity) investments. Oak Investment Partners has built a reputation for its ability to identify transformative opportunities and support them through long-term, steady guidance​. The firm is headquartered in Norwalk, Connecticut, with additional offices in California. The team includes experienced professionals like Managing Partners Bandel Carano, Ed Glassmeyer, Fred Harman, and Ann Lamont, who bring deep domain expertise and a consistent investment philosophy to the table​.

Obvious Ventures, founded in 2014 and based in San Francisco, is a venture capital firm focused on early and growth-stage investments. The firm emphasizes investments that align with their "world positive" approach, targeting sectors like planetary health, human health, and economic health. This mission-driven investment strategy seeks to support companies that create a positive impact on the world while generating significant financial returns. Notable investments by Obvious Ventures include Beyond Meat, Medable, and Dexterity. Beyond Meat, known for its plant-based meat products, went public in 2019, marking a significant milestone for the firm. Medable provides a cloud-based platform for decentralized clinical trials, while Dexterity develops AI-driven robotic systems for managing warehouses. Obvious Ventures has a diverse portfolio of over 130 companies, with successful exits including Recursion Pharmaceuticals, Lilium, and Proterra. The firm's portfolio spans various industries such as AI, biotech, fintech, and sustainable consumer goods. The team at Obvious Ventures includes co-founders Ev Williams, James Joaquin, and Vishal Vasishth, who bring extensive experience in entrepreneurship and venture capital. They are committed to supporting visionary founders who are building transformative companies.

OCA Ventures, based in Chicago, is an early-stage venture capital firm that has been investing since 1999. The firm primarily targets technology, financial services, education, and healthcare technology sectors. Their investment strategy focuses on Seed, Series A, and Series B rounds, with typical initial investments ranging from $1 to $4 million. They often lead the rounds in which they participate. Notable companies in their portfolio include SpotHero, a parking app; Base CRM, a cloud-based customer relationship management software; Pangea, an online money transfer service; and Cleversafe, a cloud-based data storage system. Other significant investments include dv01, LogicGate, and Placer.ai. OCA Ventures is also known for its OCA EDGE program, which invests $50,000 to $200,000 in seed rounds of about $1.5 million or less. This program is designed to support early-stage startups with potential for dramatic growth. The firm has a strong track record of successful exits, including the sale of Cleversafe to IBM and the IPO of Marqeta. Led by CEO Jim Dugan and co-founders John Dugan and Peter Ianello, OCA Ventures leverages a robust network of strategic relationships to support their portfolio companies and drive their growth.

Octopus Ventures, established in 2007 and headquartered in London, is a major venture capital firm in Europe with over £1.2 billion in assets under management. The firm invests in a diverse range of sectors, including B2B software, health tech, fintech, deep tech, consumer, climate, and bio. Their notable investments include well-known companies such as SwiftKey, ManyPets (formerly known as Bought By Many), Zoopla, LoveFilm, and Graze. Octopus Ventures focuses on supporting startups from pre-seed through to Series A and beyond, providing both funding and hands-on support to help companies scale. The firm is committed to backing founders with purpose-driven missions, emphasizing positive impact on people, communities, and the environment. Octopus Ventures employs a strategy that prioritizes long-term relationships with founders and deep sector expertise. They are particularly focused on disruptive technologies and innovative solutions that address significant global challenges. Recent investments reflect their commitment to sustainability and tech innovation, including companies like Token in fintech, Elliptic in blockchain analytics, and Minimum in climate tech. Led by a team of experienced investors and industry experts, Octopus Ventures ensures their portfolio companies receive the strategic guidance and operational support necessary for growth. The firm continues to expand its influence globally, aiming to foster innovation and drive positive change in the venture capital landscape.

OCV Partners is a Los Angeles-based venture capital firm, established with a mission to invest in companies that demonstrate significant growth potential, primarily in the technology and healthcare sectors. Their investment strategy is focused on mid- to late-stage companies, often in fields such as SaaS, fintech, biotech, and digital health. With a portfolio that includes innovative firms like Jukin Media, Scopely, and TaskUs, OCV Partners has positioned itself as a hands-on investor, providing both capital and operational support to help scale high-growth companies​. The firm prides itself on its diverse expertise, backing founders through every phase of their business journey. The OCV team brings decades of experience in building and scaling companies across various industries, from software and financial services to healthcare and media. They partner with startups not just to provide financial backing, but also to offer operational insight, helping businesses navigate the complexities of scaling. OCV Partners is well-known for its long-term mindset, focusing on building sustainable value through innovation and strong partnerships. The firm typically invests in companies at the seed to Series B stages, though they remain flexible and open to later-stage opportunities when appropriate.

Odyssee Venture is an independent Paris-based private-equity and venture-capital management company founded in 1999, headquartered at 26 rue de Berri in the 8th arrondissement, and one of the earliest AMF-accredited independent asset managers in France. The firm was co-founded by Mathieu Boillet and Sebastien Sassolas, who previously ran the venture-capital activities of the Banques Populaires Group through SPEF — historically France's first institutional venture investor. Over more than 25 years Odyssee has raised over EUR 750 million across FCPI, FIP, and FCPR vehicles and has financed roughly 200 French growth SMEs. Odyssee leads rounds and focuses on growth-stage investments in French SMEs spanning business and consumer products, financial services, healthcare and life sciences, SaaS, manufacturing and industrials, and e-commerce — deploying tickets from EUR 1 million to EUR 10 million with a typical average around EUR 5 million. Across 181 disclosed investments the portfolio includes BrightHeart, a prenatal ultrasound AI company for which Odyssee led an EUR 11 million Series A in January 2026 following five FDA approvals in 2025; Veesion, an AI shoplifting-gesture detection company that raised EUR 38 million to expand into the US; VitaDX, a urine-based cancer diagnostics firm; PeopleSpheres; Ekinops; Scaled Risk; and GymGlish. Odyssee's 25-year track record spans multiple economic cycles and fund formats, giving it an unusually deep bench of relationships across the French growth-company ecosystem. The firm's FCPI and FIP products are distributed to retail investors, making it one of the few French VCs with both institutional and retail LP exposure — a breadth that supports consistent capital formation across market conditions.

Offline Ventures, founded in 2020 and based in Mill Valley, California, is a venture capital firm focused on investing in early-stage startups across diverse sectors such as fintech, healthcare, and consumer technology. The firm is led by co-founders David Morin, Nate Bosshard, Brittany Morin, and James Higa, who bring extensive experience from various successful ventures. Notable investments by Offline Ventures include companies like Sunnyside, which focuses on application software; Kismet, a healthcare services company; and Clarasight, a business productivity software firm. They have a total of 48 investments and have seen several successful exits, including Diagram and Artifact. Offline Ventures is known for supporting startups that innovate at the intersection of technology and culture. They emphasize backing founders who are committed to building impactful and sustainable businesses. The firm also operates a venture studio to help incubate and develop new ideas into successful companies.

Oita Venture Capital Co., Ltd. is a regional Japanese venture capital and private equity firm headquartered in Oita City, Oita Prefecture, founded in 1997 and operating as the venture-capital arm of Oita Bank Ltd. One of Kyushu's longest-running institutional venture investors, the firm focuses almost exclusively on the Oita region and the broader Kyushu ecosystem, with occasional investments elsewhere in Japan. Oita VC specializes in growth capital, management buyouts, and turnaround investments in local small- and mid-sized enterprises, with particular emphasis on promising venture companies possessing differentiated technology or products and targeting IPO. Thematic priorities include agriculture and corporate farming, renewable energy, technology, and growth and turnaround opportunities for SMEs contributing to the regional economy. The firm leads rounds and operates a series of funds, with Oita VC Success Fund No. 6 as the current active vehicle. Across the firm's history, approximately 70 disclosed investments have been made across 61 companies, resulting in 11 IPO exits — notable listings include iQPS in satellite SAR imaging, QD Laser in semiconductor lasers, and Thinca in payments. Recent deployment has been measured at roughly one new investment per year, including INSPIRATION PLUS at Series A in 2024, GexVal in drug discovery in January 2025, and ATOMica at Series B-III in February 2026, the firm's most recent disclosed investment. Oita VC's role extends beyond financial return to regional economic development: by systematically backing and listing locally grown technology companies, the firm helps anchor high-skill employment and entrepreneurial activity in a prefecture that otherwise sits outside Japan's main technology corridors.

Okapi Venture Capital, established in 2005 and based in Newport Beach, California, focuses on seed and early-stage investments in the information technology and life sciences sectors. The firm has made 83 investments and has 18 notable exits, including companies like Welltok, Qualaroo, and CrowdStrike. Their portfolio includes a diverse range of companies such as Occuspace, which provides smart building solutions, Trellis Research in legal tech, and Daasity, which offers eCommerce analytics solutions. Other significant investments include Babylist, an online discovery platform for baby products, and ChromaCode, which uses data science for advanced molecular diagnostics. Okapi's investment strategy emphasizes supporting innovative startups with high growth potential, often leading seed and Series A rounds. The team is led by co-founders Marc Averitt and Sharon Stevenson, alongside partners like Jeff Bocan and John Waller, who bring extensive experience in venture capital and technology management. The firm is particularly active in the US market and collaborates with co-investors such as SaaS Ventures, Mucker Capital, and Stage Venture Partners, to foster the growth and success of its portfolio companies.

Olima Ventures is a New York-based early-stage venture capital firm founded in 2009 by Vijay Pandurangan, an engineer-entrepreneur-investor whose operating background includes senior engineering leadership at Twitter and the founding of Ephla Bio, a biotech company developing therapeutics targeting B-cell pathologies. Olima's thesis is to invest early in great teams creating a 'frictionless future,' concentrating in biotech, B2B software, enterprise technology, distributed systems, machine learning, privacy and security, and remote collaboration. The firm also leads biotech incubations directly, reflecting Pandurangan's scientific depth alongside his technology background. Olima writes checks ranging from $100,000 to $5 million with a sweet spot around $1.5 million, covering pre-seed, seed, and Series A stages. Across more than 15 years of deployment the firm has built a portfolio of approximately 68 companies. One portfolio company, Pilot — a bookkeeping and financial-operations platform — achieved unicorn status in 2021, four years after Olima's initial investment. Other notable positions include SpaceX, Candid — a dental aligners company — and Dieta, which was acquired by Cylinder Health in March 2025. The firm operates with a lean team of two to ten professionals. Olima's founder-operator profile is central to its value proposition: Pandurangan's own experience building at Twitter and in biotech gives the firm informed judgment on both the technical and commercial dimensions of early-stage companies. The combination of software and biotech competency under one roof is unusual at the pre-seed and seed stages and allows Olima to serve a broader range of founder types than most comparably-sized funds.

Olive Tree Capital is a dynamic venture capital firm headquartered in Boston, Massachusetts, focusing on early-stage investments across various tech-driven sectors. Notable investments include Uber, Postmates, and Lark, illustrating their keen eye for potential high-growth startups. With a strong portfolio in Artificial Intelligence, Machine Learning, Health & Wellness, and Big Data & Analytics, Olive Tree Capital seeks to back transformative companies from pre-seed through Series A stages. Their investment strategy is characterized by flexibility and an evergreen capital structure, allowing them to lead rounds and provide significant follow-on funding without the constraints of traditional fund timelines. This approach facilitates a long-term partnership with startups, aiming for substantial growth and successful exits, as demonstrated by their involvement in high-profile mergers and acquisitions like those of Bueno Finance and 10 Minute Squad. The firm’s geographic focus extends primarily across the United States, with a pronounced presence in the Boston area. Key team members, including Managing Partners Nichola Eliovits and Yamen Al-Hajjar, bring extensive experience in technology and biotechnology, reinforcing the firm's industry expertise and strategic guidance. Olive Tree Capital’s investment process emphasizes rigorous due diligence and a collaborative approach with co-investors like Y Combinator and Soma Capital. Startups seeking to engage with Olive Tree Capital are encouraged to present a compelling vision for innovation and market disruption, aligning with the firm’s commitment to transformative impact and sustainable growth​.

Omega Venture Partners, based in Palo Alto, California, is a leading venture capital firm specializing in AI, machine learning, data, and automation. Their investment strategy is centered around identifying high-growth companies at the early-growth stage, particularly those that leverage AI to solve significant business challenges. Omega's portfolio includes companies like ZenBusiness, DataRobot, Verbit, and Elemental Machines, showcasing their focus on businesses that deliver transformative solutions across industries. Omega typically invests at the inflection point of a company’s growth, providing funding between $1M and $10M per round. Their thematic approach ensures they target companies with large-scale potential, helping them scale rapidly through access to a proprietary network of Fortune 500 executives and strategic partners. This network enables Omega to deliver high-value introductions, mentorship, and go-to-market strategies, adding significant value beyond capital. The firm's leadership, including Managing Partner Gaurav Tewari, has a deep track record in tech investing. Omega's expertise in guiding AI-driven companies makes them a preferred partner for entrepreneurs seeking to revolutionize industries like healthcare, fintech, and digital transformation.

OMERS Ventures, the venture capital arm of the Ontario Municipal Employees' Retirement System, focuses on investing in Series A to C companies across North America. Founded in 2011, the firm has backed several high-profile tech companies like Shopify and Wave. Their investment strategy centers on transformative technology sectors, including fintech, healthtech, proptech, and workplace technology. Typical initial investments range from $5 million to $25 million. OMERS Ventures has decided to withdraw from the European market to concentrate its efforts on North America. This strategic shift follows a challenging market environment in Europe and aims to leverage North America's relative economic stability. As part of this transition, the firm plans to open a new office in New York while maintaining its presence in Toronto and San Francisco. The leadership team includes Michael Yang, who emphasizes the importance of building strong relationships with founders and has a background in investing in emerging areas such as healthtech and IoT. For startups looking to engage with OMERS Ventures, demonstrating a deep understanding of the market and a clear vision for growth is essential. The firm values transparency and strong founder-investor relationships, aiming to support companies through various market challenges and opportunities.

Omnes Capital is a leading European private equity firm specializing in energy transition and innovation. Founded in 1999 and based in Paris, Omnes manages over €5 billion in assets. The firm's investment strategy focuses on four core areas: renewable energy, sustainable cities, deep tech venture capital, and co-investment. Notable investments include Direct Energie, Neoen, and BioSerenity. Omnes has made significant strides in the renewable energy sector with its Capenergie funds, which have invested over €2.5 billion across more than 60 projects in Europe, transforming developers into independent power producers. For example, their Capenergie 2 fund achieved a 15% net IRR, ranking among the top performers in Europe. Omnes also plays a crucial role in sustainable urban development by financing projects that support decarbonization and resilient city infrastructure. Their deep tech investments focus on disruptive technologies and startups pushing the boundaries of innovation. In addition to financial returns, Omnes is committed to responsible investment practices. The firm supports non-profits through the Omnes Foundation, which focuses on education, health, and social integration for children. Omnes is also a signatory of the United Nations Principles for Responsible Investment (PRI), underscoring their commitment to sustainability and ethical investment​.

Omnivore is a leading venture capital firm based in India, focusing on early-stage investments in agritech and food systems. Founded in 2010 by Mark Kahn and Jinesh Shah, Omnivore aims to transform the agricultural sector by supporting startups that enhance productivity, sustainability, and profitability for smallholder farmers and rural communities. The firm’s investment themes include farmer platforms, fintech, B2B agri marketplaces, farm-to-consumer brands, precision agriculture, and post-harvest technologies​. Omnivore's portfolio features notable companies like DeHaat, BharatAgri, and Ecozen, which address critical challenges in the agriculture sector through innovative solutions. The firm recently closed the first round of its third fund, the Omnivore Agritech and Climate Sustainability Fund, with $150 million, aiming to support 25-30 new startups focused on climate-smart agriculture and agrifood life sciences​. Omnivore is also recognized for its significant impact on smallholder farmers, having created substantial economic value and improved agricultural practices across India. The firm has reached over 11.4 million smallholder farmers, enabled $1.44 billion in economic value, and facilitated loans and insurance coverage worth billions​. The investment team, led by Mark Kahn and Jinesh Shah, includes experienced partners and advisors deeply embedded in the agritech ecosystem. Their strategic investments are aimed at generating both financial returns and positive social impact​.

OneVentures is a leading Australian venture capital firm with a global focus, investing in technology and healthcare companies. The firm provides both equity and credit funding, with a particular emphasis on innovative products addressing significant market needs. OneVentures operates through several funds. Their Growth Fund V, which closed at $142 million, focuses on technology and tech-enabled companies, investing up to $20 million per company. This fund targets global themes such as remote work, digitization, clean energy, and healthcare. Additionally, the firm manages the Growth Credit Fund IV and the VGF Credit Fund, providing debt financing to high-growth tech companies, with investments ranging from $500,000 to $10 million per company. In the healthcare sector, OneVentures manages the $170 million Healthcare Fund III, investing in therapeutics, devices, and diagnostics with a clear commercial pathway. This fund is part of the Commonwealth Government’s Biomedical Translation Fund program, aiming to advance promising biomedical innovations. OneVentures' portfolio includes companies like Vaxxas, which develops needle-free vaccine delivery technology, and BiVACOR, known for its artificial heart technology. The firm is known for its hands-on approach, providing strategic guidance and leveraging its extensive network to support the growth and success of its portfolio companies.

One Way Ventures, founded in 2017 and headquartered in Boston, Massachusetts, is a venture capital firm dedicated to investing in immigrant founders. The firm focuses on seed-stage and early-stage companies across various sectors, including logistics, mobility, fintech, proptech, deep tech, consumer technology, healthcare, AI, machine learning, and robotics. Notable investments by One Way Ventures include Brex, Chipper Cash, Classtag, and Momentus. The firm has made significant exits, such as Legalpad, acquired in 2022, and Lynk, a satellite communications company​. The portfolio is diverse, featuring companies like Beacon, an AI-powered workflow automation platform for logistics; Brelyon, a deep tech company creating virtual screens; and Care Academy, a caregiver training platform. Co-founded by Semyon Dukach and Eveline Buchatskiy, One Way Ventures aims to support high-impact global companies driven by the unique perspectives and experiences of immigrant founders. The firm values equal opportunity and the collective potential of humankind, striving to eliminate borders as barriers to innovation and growth​.

OneRagtime is a venture capital platform that focuses on sourcing, financing, and scaling early-stage tech startups across Europe. Founded by Stéphanie Hospital and Jean-Marie Messier, the firm offers a unique investment model that combines flexibility with a fully digitized process, allowing investors to choose how they invest, either through deal-by-deal or via their funds like OneRagtime Rhapsody II and OneRagtime Paragon. The firm invests primarily in seed and Series A stages, with initial investments ranging from €0.5 million to €3 million, and can follow up with investments up to €10 million. OneRagtime targets startups in several sectors, including consumer platforms (gaming, marketplaces, social media, and the creator economy), artificial intelligence, cloud services, cybersecurity, and tech for social good (education, climate, and health). Notable portfolio companies include Groover, an artist promotion platform; PhantomBuster, a no-code data automation tool; and Benefiz, an HR tech platform for managing employee benefits. OneRagtime also emphasizes providing strategic, operational, and business development support to its portfolio companies to ensure their growth and success. With a community-driven approach, OneRagtime offers investors the opportunity to engage deeply with startups, providing not just capital but also expertise and networks to drive innovation and growth in the tech sector.

ONSET Ventures was a storied early-stage venture capital firm founded in 1984 and headquartered in Menlo Park, California. The firm was co-founded by Terry Opdendyk, who served as Founder and General Partner across 30-plus years; David Kelley, the founder of IDEO; and Michael Levinthal. For nearly four decades ONSET specialized in seed and Series A investments in information technology and medical sectors — spanning infrastructure software, media, medical devices, drug delivery, mobile, diagnostics, and broader healthcare. The long-tenured partner bench included Rob Kuhling, who joined as Partner in 1987 following his time at Sun Microsystems, and Shomit Ghose. Over its lifetime ONSET raised nine funds and managed more than $1 billion in cumulative assets under management, backing more than 130 companies and producing four IPOs and 42 acquisitions. Notable exits include Adaptive Insights, the financial planning and analytics platform acquired by Workday for $1.55 billion; NeuroStar, an FDA-cleared transcranial magnetic stimulation device for major depressive disorder; CallidusCloud, a sales performance management platform acquired by SAP; and Apama Medical, a chronic-pain therapy company focused on basivertebral nerve treatment. The firm leads rounds and was particularly active at Series A with an average round size of approximately $8.8 million. ONSET Ventures was officially dissolved on November 27, 2023 and is no longer an active investor. Its website and portfolio documentation are maintained for historical reference. The firm's four-decade run across Silicon Valley's technology and medical-device buildout represents one of the most consistent early-stage track records of its era.

OpenSpace Ventures is a prominent venture capital firm based in Southeast Asia, known for its strategic investments in transformative tech companies across the region. Established in 2014, OpenSpace Ventures has backed notable companies like Gojek, Halodoc, and Love, Bonito, which have made significant impacts in their respective industries. The firm focuses on sectors such as fintech, healthcare, e-commerce, and digital media. Their portfolio includes companies like Lista, a financial management platform for individuals and small business owners in the Philippines; Lucence, a precision oncology company; and Nutrition Technologies, which produces sustainable insect-based proteins for agriculture. OpenSpace Ventures employs a hands-on approach, providing not only capital but also strategic guidance and operational support to help their portfolio companies scale and succeed. They manage several funds, including those focused on Series A/B and mid-stage growth investments, and are recognized for their deep expertise and active involvement in the Southeast Asian startup ecosystem​.